These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 38410599)
1. Thromboembolism in peripartum cardiomyopathy: a systematic review. Radakrishnan A; Dokko J; Pastena P; Kalogeropoulos AP J Thorac Dis; 2024 Jan; 16(1):645-660. PubMed ID: 38410599 [TBL] [Abstract][Full Text] [Related]
2. Unveiling the Mystery of Peripartum Cardiomyopathy: A Traditional Review. Chinweuba GC; Rutkofsky IH Cureus; 2020 Oct; 12(10):e10790. PubMed ID: 33042652 [TBL] [Abstract][Full Text] [Related]
3. A Systematic Review of the Utility of Bromocriptine in Acute Peripartum Cardiomyopathy. Badianyama M; Das PK; Gaddameedi SR; Saukhla S; Nagammagari T; Bandari V; Mohammed L Cureus; 2021 Sep; 13(9):e18248. PubMed ID: 34603902 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy: a proof-of-concept pilot study. Sliwa K; Blauwet L; Tibazarwa K; Libhaber E; Smedema JP; Becker A; McMurray J; Yamac H; Labidi S; Struman I; Hilfiker-Kleiner D Circulation; 2010 Apr; 121(13):1465-73. PubMed ID: 20308616 [TBL] [Abstract][Full Text] [Related]
6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
7. Left ventricular function recovery in peripartum cardiomyopathy: a cardiovascular magnetic resonance study by myocardial T1 and T2 mapping. Liang YD; Xu YW; Li WH; Wan K; Sun JY; Lin JY; Zhang Q; Zhou XY; Chen YC J Cardiovasc Magn Reson; 2020 Jan; 22(1):2. PubMed ID: 31902370 [TBL] [Abstract][Full Text] [Related]
8. Venous thromboembolism prophylaxis for women at risk during pregnancy and the early postnatal period. Middleton P; Shepherd E; Gomersall JC Cochrane Database Syst Rev; 2021 Mar; 3(3):CD001689. PubMed ID: 33779986 [TBL] [Abstract][Full Text] [Related]
9. Risk for ventricular fibrillation in peripartum cardiomyopathy with severely reduced left ventricular function-value of the wearable cardioverter/defibrillator. Duncker D; Haghikia A; König T; Hohmann S; Gutleben KJ; Westenfeld R; Oswald H; Klein H; Bauersachs J; Hilfiker-Kleiner D; Veltmann C Eur J Heart Fail; 2014 Dec; 16(12):1331-6. PubMed ID: 25371320 [TBL] [Abstract][Full Text] [Related]
12. Rationale and design of a randomized, controlled multicentre clinical trial to evaluate the effect of bromocriptine on left ventricular function in women with peripartum cardiomyopathy. Haghikia A; Podewski E; Berliner D; Sonnenschein K; Fischer D; Angermann CE; Böhm M; Röntgen P; Bauersachs J; Hilfiker-Kleiner D Clin Res Cardiol; 2015 Nov; 104(11):911-7. PubMed ID: 26026286 [TBL] [Abstract][Full Text] [Related]
13. Pulmonary thromboembolism presenting with chest pain in a case of peripartum cardiomyopathy. Mahmoudi E; Tabary M; Khaheshi I Future Cardiol; 2020 Jul; 16(4):263-269. PubMed ID: 32180452 [TBL] [Abstract][Full Text] [Related]
14. Pathophysiology, diagnosis and management of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy. Bauersachs J; König T; van der Meer P; Petrie MC; Hilfiker-Kleiner D; Mbakwem A; Hamdan R; Jackson AM; Forsyth P; de Boer RA; Mueller C; Lyon AR; Lund LH; Piepoli MF; Heymans S; Chioncel O; Anker SD; Ponikowski P; Seferovic PM; Johnson MR; Mebazaa A; Sliwa K Eur J Heart Fail; 2019 Jul; 21(7):827-843. PubMed ID: 31243866 [TBL] [Abstract][Full Text] [Related]
15. Peripartum cardiomyopathy in Iraq: initial registry-based data and 6 month outcomes. Farhan HA; Yaseen IF ESC Heart Fail; 2021 Oct; 8(5):4048-4054. PubMed ID: 34184413 [TBL] [Abstract][Full Text] [Related]
16. Outcome in German and South African peripartum cardiomyopathy cohorts associates with medical therapy and fibrosis markers. Azibani F; Pfeffer TJ; Ricke-Hoch M; Dowling W; Pietzsch S; Briton O; Baard J; Abou Moulig V; König T; Berliner D; Libhaber E; Schlothauer S; Anthony J; Lichtinghagen R; Bauersachs J; Sliwa K; Hilfiker-Kleiner D ESC Heart Fail; 2020 Apr; 7(2):512-522. PubMed ID: 32064780 [TBL] [Abstract][Full Text] [Related]
17. Bromocriptine treatment in patients with peripartum cardiomyopathy and right ventricular dysfunction. Haghikia A; Schwab J; Vogel-Claussen J; Berliner D; Pfeffer T; König T; Zwadlo C; Moulig VA; Franke A; Schwarzkopf M; Ehlermann P; Pfister R; Michels G; Westenfeld R; Stangl V; Kühl U; Podewski E; Kindermann I; Böhm M; Sliwa K; Hilfiker-Kleiner D; Bauersachs J Clin Res Cardiol; 2019 Mar; 108(3):290-297. PubMed ID: 30121697 [TBL] [Abstract][Full Text] [Related]
18. Effects of bromocriptine in peripartum cardiomyopathy: a systematic review and meta-analysis. Trongtorsak A; Kittipibul V; Mahabir S; Ibrahim M; Saint Croix GR; Hernandez GA; Chaparro S Heart Fail Rev; 2022 Mar; 27(2):533-543. PubMed ID: 34725781 [TBL] [Abstract][Full Text] [Related]
19. Peripartum cardiomyopathy: An epidemiologic study of early and late presentations. Masoomi R; Shah Z; Arany Z; Gupta K Pregnancy Hypertens; 2018 Jul; 13():273-278. PubMed ID: 30177065 [TBL] [Abstract][Full Text] [Related]
20. A new risk score for the assessment of outcomes for Chinese patients with peripartum cardiomyopathy. Zhang Z; Zheng W; Chen M; Xie Q; Huang M; Li W; Huang Z Heart Lung; 2023; 60():81-86. PubMed ID: 36933287 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]